[WCN23_Free Paper]

MS & Demyelinating Diseases

SMALLER OPTIC NERVE DIAMETERS AND REDUCED FLOW VELOCITY OF OPHTHALMIC ARTERY SUGGEST A HISTORY OF OPTIC NEURITIDES: TRANSORBITAL ULTRASONOGRAPHY AND DOPPLER ULTRASOUND IN MULTIPLE SCLEROSIS. 
Nicola Merli (Italy)

EFFICACY AND SAFETY OF RAVULIZUMAB IN ADULTS WITH ANTI-AQUAPORIN-4 ANTIBODY-POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: OUTCOMES FROM THE PHASE 3 CHAMPION-NMOSD TRIAL
Jacqueline Palace (United Kingdom)

EFFICACY AND SAFETY OF RITUXIMAB (RTX) IN MOROCCAN MULTIPLE SCLEROSIS (MS) PATIENTS
Maria Benabdeljlil (Morocco)

MOBILISE-D: THE LARGEST OBSERVATIONAL TRIAL OF DIGITAL MOBILITY OUTCOME MEASURES IN MULTIPLE SCLEROSIS
Gavin Brittain (United Kingdom)

PREDICTIVE BIOMARKER IDENTIFICATION OF PATIENT-REPORTED OUTCOMES IN PERSONS WITH MS TREATED WITH AHSCT
Moisés M. Gallardo-Pérez (Mexico)

AQUAPORIN-4 ANTIBODY DYNAMICS AND RELAPSE RISK IN SEROPOSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER TREATED WITH IMMUNOSUPPRESSANTS
Yan Xu (China)